Eisai
4523.TPharmaceutical
Financials · Standalone
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥386.3bn | ¥376.4bn | ¥367.4bn | ¥359.9bn | ¥417.1bn | ¥345.7bn |
| Operating income | ¥9.7bn | ¥34.6bn | ¥23.0bn | −¥3.9bn | ¥14.6bn | ¥7.1bn |
| Ordinary income | ¥12.9bn | ¥35.0bn | ¥24.5bn | −¥206m | ¥14.1bn | ¥8.4bn |
| Total assets | ¥710.3bn | ¥739.3bn | ¥743.9bn | ¥742.1bn | ¥822.3bn | ¥746.6bn |
| Net assets / equity | ¥368.0bn | ¥395.0bn | ¥430.2bn | ¥454.5bn | ¥465.9bn | ¥507.0bn |
| EPS (basic) | ¥73.94 | ¥146.72 | ¥70.82 | ¥106.43 | ¥23.51 | ¥24.59 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2026-03-31 | Annual | 204 figures · EDINET |
| 2025-04-01 → 2025-09-30 | Half-year | 77 figures · EDINET |
| 2024-04-01 → 2025-03-31 | Annual | 206 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 77 figures · EDINET |
| 2023-04-01 → 2024-03-31 | Annual | 212 figures · EDINET |
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 104 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 104 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 82 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 212 figures · EDINET |
| 2022-04-01 → 2022-12-31 | Quarterly Q3 | 106 figures · EDINET |
| 2022-04-01 → 2022-09-30 | Quarterly Q2 | 106 figures · EDINET |
| 2022-04-01 → 2022-06-30 | Quarterly Q1 | 82 figures · EDINET |
| 2021-04-01 → 2022-03-31 | Annual | 212 figures · EDINET |
21 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Americas | ¥300.4bn | ¥174.4bn |
| China | ¥130.7bn | ¥59.3bn |
| East Asia Global South | ¥68.8bn | ¥30.2bn |
| EMEA | ¥81.5bn | ¥30.4bn |
| Japan | ¥229.2bn | ¥73.0bn |
| Other segments | ¥14.6bn | ¥4.5bn |
| Total | ¥810.8bn | ¥367.3bn |
| Total | ¥825.4bn | ¥371.8bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.